Xeris Biopharma Holdings, Inc. SEC filings XERS

Xeris Biopharma Holdings, Inc. has 345 filings in SEC EDGAR's recent list, going back to Jul 2, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Xeris Biopharma Holdings, Inc. SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 5, 2026 —
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
3 Initial insider ownership Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2026 —
4 Insider transaction Oct 2, 2026 Oct 1, 2026
4 Insider transaction Oct 2, 2026 Oct 1, 2026
4 Insider transaction Oct 2, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 29, 2026 Sep 28, 2026
144 Notice of proposed sale Sep 28, 2026 —
4 Insider transaction Sep 1, 2026 Sep 1, 2026
4 Insider transaction Sep 1, 2026 Sep 1, 2026
4 Insider transaction Sep 1, 2026 Sep 1, 2026
4 Insider transaction Aug 21, 2026 Aug 1, 2026
4 Insider transaction Aug 21, 2026 Aug 1, 2026
4 Insider transaction Aug 12, 2026 Aug 12, 2026
144 Notice of proposed sale Aug 12, 2026 —
4 Insider transaction Aug 4, 2026 Aug 3, 2026
4 Insider transaction Aug 4, 2026 Aug 3, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 31, 2026 —
4 Insider transaction Jul 7, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 2, 2026 Jul 1, 2026
3 Initial insider ownership Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
144 Notice of proposed sale Jun 4, 2026 —
144 Notice of proposed sale Jun 4, 2026 —
144 Notice of proposed sale Jun 4, 2026 —
144 Notice of proposed sale Jun 3, 2026 —
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction May 1, 2026 May 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
144 Notice of proposed sale Mar 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 5, 2026 Mar 5, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 25, 2026 Feb 24, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 9, 2026 Jan 8, 2026
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Jan 6, 2026 Jan 5, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
144 Notice of proposed sale Dec 19, 2025 —
4 Insider transaction Dec 19, 2025 Dec 19, 2025
4 Insider transaction Dec 15, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 13, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 13, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
4 Insider transaction Oct 3, 2025 Oct 2, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 12, 2025 Sep 11, 2025
144 Notice of proposed sale Sep 11, 2025 —
4 Insider transaction Aug 29, 2025 Aug 28, 2025
144 Notice of proposed sale Aug 28, 2025 —
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
144 Notice of proposed sale Aug 13, 2025 —
144 Notice of proposed sale Aug 12, 2025 —
4 Insider transaction Aug 4, 2025 Aug 1, 2025
4 Insider transaction Aug 4, 2025 Aug 1, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 4, 2025 Jun 4, 2025
4 Insider transaction Jun 4, 2025 Jun 4, 2025
4 Insider transaction Jun 4, 2025 Jun 4, 2025
4 Insider transaction Jun 4, 2025 Jun 4, 2025
4 Insider transaction Jun 4, 2025 Jun 4, 2025
4 Insider transaction Jun 4, 2025 Jun 4, 2025
144 Notice of proposed sale May 9, 2025 —
4 Insider transaction Apr 3, 2025 Apr 2, 2025
4 Insider transaction Mar 28, 2025 Mar 28, 2025
3 Initial insider ownership Mar 28, 2025 Mar 28, 2025
4 Insider transaction Mar 21, 2025 Mar 20, 2025
144 Notice of proposed sale Mar 20, 2025 —
3 Initial insider ownership Mar 7, 2025 Feb 25, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Nov 26, 2024 Nov 22, 2024
4 Insider transaction Aug 13, 2024 Aug 12, 2024
4 Insider transaction Aug 12, 2024 Aug 9, 2024
4 Insider transaction Aug 9, 2024 Jan 29, 2022
4 Insider transaction Aug 9, 2024 Jan 29, 2022
4 Insider transaction Aug 9, 2024 Jan 29, 2022
4 Insider transaction Aug 2, 2024 Jan 29, 2022
4 Insider transaction Aug 2, 2024 Aug 1, 2024
3 Initial insider ownership Aug 2, 2024 Aug 1, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction Jun 5, 2024 Jun 5, 2024
4 Insider transaction May 10, 2024 May 10, 2024
4 Insider transaction Apr 11, 2024 Mar 15, 2024
4 Insider transaction Apr 1, 2024 Mar 15, 2024
4 Insider transaction Apr 1, 2024 Mar 15, 2024
4 Insider transaction Mar 18, 2024 Mar 18, 2024
4 Insider transaction Mar 14, 2024 Mar 14, 2024
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Jan 31, 2024 Jan 31, 2024
4 Insider transaction Jan 31, 2024 Jan 31, 2024
4 Insider transaction Jan 31, 2024 Jan 31, 2024
4 Insider transaction Jan 31, 2024 Jan 31, 2024
4 Insider transaction Jan 31, 2024 Jan 31, 2024
SC 13G Ownership over 5% (passive) Jan 26, 2024 —
4 Insider transaction Nov 29, 2023 Nov 27, 2023
4 Insider transaction Nov 21, 2023 Nov 20, 2023
4 Insider transaction Nov 21, 2023 Nov 20, 2023
4 Insider transaction Nov 17, 2023 Nov 16, 2023
4 Insider transaction Nov 17, 2023 Nov 17, 2023
4 Insider transaction Nov 15, 2023 Nov 14, 2023
4 Insider transaction Aug 9, 2023 Aug 9, 2023
4 Insider transaction Jun 7, 2023 Jun 7, 2023
4 Insider transaction Jun 7, 2023 Jun 7, 2023
4 Insider transaction Jun 7, 2023 Jun 7, 2023
4 Insider transaction Jun 7, 2023 Jun 7, 2023
4 Insider transaction Jun 7, 2023 Jun 7, 2023
4 Insider transaction Jun 7, 2023 Jun 7, 2023
4 Insider transaction Jun 7, 2023 Jun 7, 2023
4 Insider transaction Mar 29, 2023 Mar 27, 2023
3 Initial insider ownership Mar 29, 2023 Mar 27, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
SC 13G Ownership over 5% (passive) Feb 10, 2023 —
4 Insider transaction Feb 1, 2023 Jan 31, 2023
4 Insider transaction Feb 1, 2023 Jan 31, 2023
4 Insider transaction Feb 1, 2023 Jan 31, 2023
4 Insider transaction Feb 1, 2023 Jan 31, 2023
4 Insider transaction Feb 1, 2023 Jan 31, 2023
4 Insider transaction Feb 1, 2023 Jan 31, 2023
4 Insider transaction Dec 14, 2022 Dec 13, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
4 Insider transaction May 13, 2022 May 12, 2022
4 Insider transaction Feb 24, 2022 Feb 22, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 11, 2022 —
SC 13G Ownership over 5% (passive) Jan 14, 2022 —
4 Insider transaction Jan 5, 2022 Jan 3, 2022
4 Insider transaction Jan 5, 2022 Jan 3, 2022
4 Insider transaction Jan 5, 2022 Jan 3, 2022
4 Insider transaction Jan 5, 2022 Jan 3, 2022
4 Insider transaction Jan 5, 2022 Jan 3, 2022
4 Insider transaction Jan 5, 2022 Jan 3, 2022
SC 13G Ownership over 5% (passive) Jan 5, 2022 —
4 Insider transaction Nov 16, 2021 Nov 15, 2021
4 Insider transaction Nov 12, 2021 Nov 11, 2021
4 Insider transaction Nov 12, 2021 Nov 11, 2021
4 Insider transaction Nov 12, 2021 Nov 10, 2021
4/A Form 4/a submission Oct 8, 2021 Oct 5, 2021
4/A Form 4/a submission Oct 8, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021
4 Insider transaction Oct 5, 2021 Oct 5, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XERS (Nasdaq)
Fiscal year ends
December 31
Headquarters
Chicago, IL
SEC filer status
Large accelerated filer
SEC CIK
1867096

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.